| Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 674.14 k | 674.14 k | 674.14 k | 674.14 k | 674.14 k | 674.14 k |
| Cash burn (monthly) | (no burn) | 9.26 k | 110.41 k | 109.83 k | 219.05 k | 121.04 k |
| Cash used (since last report) | n/a | 275.86 k | 3.29 mm | 3.27 mm | 6.53 mm | 3.61 mm |
| Cash remaining | n/a | 398.27 k | -2.62 mm | -2.60 mm | -5.85 mm | -2.93 mm |
| Runway (months of cash) | n/a | 43.0 | -23.7 | -23.7 | -26.7 | -24.2 |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 28.49 mm |
| Total shares | 2.81 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| 5:01 Acquisition | 2.31 mm | $23.49 mm |
| Biotechnology Value Fund L P | 500.00 k | $5.00 mm |
